secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001213900-24-078288
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma obtains partial deferral of milestone payment to Dr. Reddy's under LYMPHIR deal
--------------------------------------------------------------------------------

- Dr. Reddy's agreed to partial deferral without penalty of a milestone payment due Sep 9, 2024.
- Milestone was triggered by FDA approval of LYMPHIR under the 2021 Asset Purchase Agreement.
- Payment is by Citius Oncology, Inc.; Citius Pharmaceuticals, Inc. remains guarantor.
- All other terms and conditions of the Asset Purchase Agreement remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024078288/0001213900-24-078288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024078288/ea0214420-8k_citiuspharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-078288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer